Introduction of our board members.
(As of June 21, 2024)

Directors

Isao Teshirogi, Ph.D. Representative Director, President and CEO

Isao Teshirogi

▼ Reasons for appointment

Isao Teshirogi became Representative Director and President in 2008. He has actively pushed forward with global research and development and expansion of global business to achieve the Third Medium-Term Business Plan and secured a medium- to long-term profit foundation. After achieving the quantitative targets of “Shionogi Growth Strategy 2020 (SGS2020),” formulated in FY2014, he updated the quantitative targets in October 2016 and also achieved these targets ahead of schedule. In 2020, he started a new Medium-Term Business Plan “Shionogi Transformation Strategy 2030 (STS2030),” that includes the Company’s vision toward 2030, “Building Innovation Platforms to Shape the Future of Healthcare.” As the path toward realizing the 2030 vision has become clearer due to the plan’s initiatives, he re-established the plan in June 2023 as the “STS2030 Revision” and has vigorously moved forward the business transformation with the aim of achieving further growth. 

▼ Career summary
April 1982
Joined the Company
January 1999
General Manager, Secretary Office and General Manager, Corporate Planning Department
June 2002
Director of the Company
October 2002
General Manager, Corporate Planning Department
April 2004
Executive Officer and Executive General Manager, Pharmaceutical Research & Development Division
April 2006
Senior Executive Officer and Executive General Manager, Pharmaceutical Research & Development Division
April 2007
Senior Executive Officer
April 2008
Representative Director and President and CEO of the Company
June 2021
Outside Director, Sumitomo Mitsui Banking Corporation (incumbent) 
March 2022
Outside Director, AGC Inc. (incumbent)
July 2022
Representative Director, President and CEO of the Company (incumbent)
June 2024
Outside Director, Japan Exchange Group, Inc. (incumbent)
Major concurrent posts

Outside Director, Sumitomo Mitsui Banking Corporation

Outside Director, AGC Inc.

Outside Director, Japan Exchange Group, Inc. 

Attended all 13 Board of Directors meetings of FY2023.

Takuko Sawada Director and Vice Chairperson of the Board

Takuko Sawada

▼ Reasons for appointment

Since her appointment as a Director of the Company in June 2015, Takuko Sawada has been responsible for business execution of the Corporate Strategy Division as Senior Vice President of the Corporate Strategy Division and as a Senior Executive Officer. She became Vice President in April 2018 and has been supervising the Integrated Disease Care Division, Corporate Strategy Division, Pharmaceutical Commercial Division and DX Promotion Division to achieve the Medium-Term Business Plan “Shionogi Transformation Strategy 2030 (STS2030)” and its revised version, “STS2030 Revision,” since April 2020. Furthermore, she has been in charge of supervising management from a higher standpoint as Director and Vice Chairperson since July 2022.

▼ Career summary
April 1977
Joined the Company
April 2002
Executive General Manager, Pharmaceutical Development Division
April 2007
Officer and Executive General Manager, Pharmaceutical Development Division
April 2010
Executive Officer and Executive General Manager, Pharmaceutical Development Division
April 2011
Senior Executive Officer and Executive General Manager, Global Development Office
April 2013
Senior Executive Officer and Senior Vice President, Global Development and, Pharmaceutical Development Division
April 2014
Senior Executive Officer and Senior Vice President, Global Pharmaceutical Development Division
April 2015
Senior Executive Officer and Senior Vice President, Corporate Strategy Division
June 2015
Director of the Company and Senior Executive Officer and Senior Vice President, Corporate Strategy Division
October 2015
Senior Executive Officer and Senior Vice President, Corporate Strategy Division, and General Manager, Corporate Planning Department
April 2016
Senior Executive Officer and Senior Vice President, Corporate Strategy Division
April 2017
Senior Executive Officer and Senior Vice President, Corporate Strategy Division
April 2018
Director of the Company and Executive Vice President
Aplil 2020
Director of the Company and Executive Vice President and Senior Vice President of Integrated disease care Division
July 2022
Director and Vice Chairperson of the Board (incumbent)
June 2023
Outside Director, Konica Minolta Inc. (incumbent)
Major concurrent posts
Outside Director, Konica Minolta Inc.

Attended all 13 Board of Directors meetings of FY2023.

Outside Directors

Keiichi Ando Outside Director(Independent Director)(Chairperson of the Board of Directors)

Keiichi Ando

▼ Reasons for appointment

Keiichi Ando has practical experience as a corporate executive at a financial institution and broad insight on finance. He also coordinated the extremely difficult adjustments between the national government and the governments of Osaka Prefecture and Osaka City for the airport management business of Kansai, which was then at a crossroads, and his experience and insight built the foundation of Kansai Airports, which plays a leading role in the current Kansai economy. At the Company’s Board of Directors meetings, he presents many questions and opinions and provides sound advice from the perspective of budget planning and management, capital policies, including investments, and risk management to the ensure effective use of important management resources, while, as chair of the Board, taking into account the timeliness and appropriateness of the proposals. Thus, he recognizes the corporate responsibility we should fulfill and makes management decisions with an emphasis on objectivity and impartiality, without bias in favor of corporate executives or specific interested parties.

▼ Career summary
April 1976
Joined Sumitomo Bank Limited (now Sumitomo Mitsui Banking Corporation)
April 2003
Executive Officer, Sumitomo Mitsui Banking Corporation
April 2006
Managing Executive Officer, Sumitomo Mitsui Banking Corporation
April 2009
Director and Senior Managing Executive Officer, Sumitomo Mitsui Banking Corporation
April 2010
Representative Director and Deputy President and Executive Officer, Sumitomo Mitsui Banking Corporation
April 2012
Representative Director and President, NEW KANSAI INTERNATIONAL AIRPORT COMPANY, LTD
July 2012
Representative Director and President and CEO, NEW KANSAI INTERNATIONAL AIRPORT COMPANY, LTD.
June 2016
Outside Director of the Company (incumbent)
June 2016
Representative Director and President, GINSEN CO., LTD. 
June 2017
Outside Director, Tsubakimoto Chain Co. (incumbent)
June 2019
Outside Director, DAIHEN Corporation (incumbent)
Major concurrent posts

Outside Director, Tsubakimoto Chain Co.

Outside Director, DAIHEN Corporation

Attended all 13 Board of Directors meetings of FY2023.

Hiroshi Ozaki Outside Director(Independent Director)

Hiroshi Ozaki

▼ Reasons for appointment

Hiroshi Ozaki has abundant practical experience and wide-ranging knowledge in corporate management and organizational management as a manager of a company based in Kansai. He is also the former chairman of the Osaka Chamber of Commerce and Industry, and during his tenure promoted the economic growth of Osaka and Kansai based on the medium-term plan he developed, as well as focusing on promoting the life science industry. At the Company’s Board of Directors meetings, he raises many pertinent questions and provides sound advice on business matters, including investments and business alliances, as well as marketing and supply chains. Accordingly, he makes management decisions with an emphasis on objectivity and neutrality based on his extensive experience and knowledge.

▼ Career summary
May 1972
Joined Osaka Gas Co., Ltd.
June 2000
Director, Osaka Gas Co., Ltd.
June 2002
Director and Tokyo Representative, Osaka Gas Co., Ltd., on loan to the Japan Gas Association
June 2005
Managing Director and General Manager of LNG Terminal and Power Generation Business Unit, Osaka Gas Co., Ltd.
June 2007
Managing Director and General Manager of Commercial & Industrial Energy Business Unit, Osaka Gas Co., Ltd.
April 2008
Representative Director and President, Osaka Gas Co., Ltd.
June 2008
Director, Osaka Gas Chemicals Co., Ltd. 
June 2009
Representative Director and President, Operating Executive Officer, Osaka Gas Co., Ltd.
June 2009
Director, OGIS-RI Co., Ltd. 
June 2011
Outside Director, Asahi Broadcasting Corporation (now Asahi Broadcasting Group Holdings Corporation) 
April 2015
Representative Director and Chairman, Osaka Gas Co., Ltd. 
June 2019
Outside Director of the Company (incumbent)
January 2021
Director and Senior Advisor, Osaka Gas Co., Ltd. 
June 2021
Senior Advisor, Osaka Gas Co., Ltd. (incumbent)
June 2021
Outside Director, The Royal Hotel, Ltd. (incumbent) 
June 2024
Outside Director, Hiroshima Gas Co., Ltd. (incumbent) 
Major concurrent posts

Outside Director, The Royal Hotel, Ltd. 

Outside Director, Hiroshima Gas Co., Ltd.

Attended all 13 Board of Directors meetings of FY2023.

Fumi Takatsuki Outside Director(Independent Director)

Fumi Takatsuki

▼ Reasons for appointment

Fumi Takatsuki has extensive experience and professional insight from her position as an attorney in international corporate law and in legal response relating to the Chinese life science and healthcare industry. Although she has not been involved in company management in any capacity other than as an outside director in the past, at the Company’s Board of Directors meetings, she presents questions particularly concerning business expansion in Asia, including China, from an international corporate legal perspective, as well as providing sound advice on compliance. Accordingly, she makes fair management decisions from a global perspective, giving priority to legal compliance and social norms.

▼ Career summary
October 2000
Registration of Attorney at Law
October 2000
Joined Oike Law Offices
December 2003
Joined Anderson Mori & Tomotsune Law Offices
February 2004
Service at Beijing Office of Anderson Mori & Tomotsune Law Offices
April 2006
Joined Oh-Ebashi LPC & Partners 
January 2009
Partner, Oh-Ebashi LPC & Partners (incumbent) 
June 2020
Outside Director of the Company (incumbent)
June 2023
Outside Corporate Auditor, Sankyo Seiko Co., Ltd. (incumbent)
June 2024
Outside Corporate Auditor, Daikin Industries, Inc. (incumbent)
Major concurrent posts

Partner, Oh-Ebashi LPC & Partners

Outside Corporate Auditor, Sankyo Seiko Co., Ltd. 

Outside Corporate Auditor, Daikin Industries, Inc.

Attended all 13 Board of Directors meetings of FY2023.

Takaoki Fujiwara Outside Director(Independent Director)

Takaoki Fujiwara

▼ Reasons for appointment

Takaoki Fujiwara has extensive practical experience and a wide range of knowledge as a manager of a group of companies engaged in urban transport, real estate and entertainment, mainly in the Kansai area. At the Company’s Board of Directors meetings, he provides sound advice, mainly on human resource management and compliance. Accordingly, he makes decisions that emphasize objectivity and neutrality based on his extensive experience and knowledge. 

▼ Career summary
April 1975
Joined Hanshin Electric Railway Co., Ltd.
June 2005
Director, Hanshin Electric Railway Co., Ltd.
June 2007
Managing Director, Hanshin Electric Railway Co., Ltd.
April 2011
Representative Director and President, Hanshin Electric Railway Co., Ltd.
June 2011
Director, Hankyu Hanshin Holdings, Inc.
April 2015
Chairman and Representative Director, Hanshin Hotel Systems, Co., Ltd.
April 2017
Chairman of the Board of Directors and Representative Director, Hanshin Electric Railway Co., Ltd. 
June 2017
Representative Director, Hankyu Hanshin Holdings, Inc. 
June 2017
Outside Director, Sanyo Electric Railway Co., Ltd. 
December 2017
Director, Hanshin Hotel Systems
June 2018
Outside Corporate Auditor of the Company
April 2023
Advisor, Hanshin Electric Railway Co., Ltd. (incumbent)
June 2023
Outside Director of the Company (incumbent)

Attended all 11 Board of Directors meetings of FY2023.

Standing Corporate Auditors

Akira Okamoto Standing Corporate Auditor

Akira Okamoto

▼ Reasons for appointment

Akira Okamoto has served as General Manager of administrative units, including the Business Support Center and the Personnel Department, and is well-versed in corporate management. He provides appropriate recommendations and advice on the management decisions and execution of duties by the Directors from an independent point of view as a Corporate Auditor, leveraging his experience in being involved in enhancing the Company’s corporate governance and upgrading and operating the internal control system as General Manager of the Internal Control Department.

▼ Career summary
April 1978
Joined the Company
April 2006
General Manager, Business Support Center
April 2007
General Manager, General Affairs & Personnel Department
April 2008
General Manager, Human Resources Department
April 2011
General Manager, Internal Control Department
June 2015
Standing Corporate Auditor of the Company (incumbent)

Attended all 13 Board of Directors meetings of FY2023.

Attended all 11 Board of Corporate Auditors meetings of FY2023.

Noriyuki Kishida Standing Corporate Auditor

Ikuo Kato

▼ Reasons for appointment

Noriyuki Kishida has served as the head of administrative units, including the Corporate Communications Office, the Human Resources Department and the Administration Division, and is well-versed in corporate management and corporate governance. He has extensive experience and a wide range of knowledge in corporate management in general, including management strategies, through his track record in promoting internal reforms based on the management infrastructure strategy of the Medium-Term Business Plan “Shionogi Transformation Strategy 2030 (STS2030)” as Senior Vice President of the Corporate Supervisory Unit. 

▼ Career summary
April 1984
Joined the Company
October 2004
General Manager, Corporate Communications Office
April 2009
General Manager, Corporate Communications Office and  Secretary Office
April 2011
General Manager, Human Resources Department
April 2017
Corporate Officer and General Manager, Human Resources and General Administration Department
April 2020
Senior Executive Officer and Senior Vice President, Administration Division
July 2021
Senior Executive Officer and Senior Vice President, Administration Division and General Manager of Legal Affairs Department
July 2022
Senior Executive Officer and Senior Vice President, Corporate Supervisory Unit
June 2024
Standing Corporate Auditor of the Company (incumbent)

Outside Corporate Auditors

Tsuguoki Fujinuma Outside Corporate Auditor(Independent Corporate Auditor)

Tsuguoki Fujinuma

▼ Reasons for appointment

Tsuguoki Fujinuma has professional expertise in finance and accounting. He has held many important posts, including Chairman and President of the Japanese Institute of Certified Public Accountants, and has extensive experience and broad insight as outside director and outside corporate auditor of a wide range of companies. Although he has not been involved in company management in any capacity other than as an outside executive in the past, he performs higher-quality audits of the Company from the perspective of finance and accounting based on his extensive experience as a certified public accountant. He also provides appropriate advice mainly from the finance, accounting, and sustainability viewpoint at the Board of Directors and Board of Corporate Auditors meetings.

Accordingly, we expect him to reflect his experience in the audits of the Company concerning the appropriateness of the management decisions and execution of duties by the directors from an independent point of view as an outside corporate auditor. 

▼ Career summary
April 1969
Joined Horie Morita Accounting Firm
June 1970
Joined Arthur & Young Accounting Firm
May 1986
Partner and Representative Partner, Asahi Shinwa Accounting Firm (now KPMG AZSA LLC)
July 1993
Managing Partner, Ota Showa & Co. (now Ernst & Young ShinNihon LLC) (Resignation in June 2007)
May 2000
President, The International Federation of Accountants (IFAC)
July 2004
Chairman and President, The Japanese Institute of Certified Public Accountants
February 2005
Trustee, The IFRS Foundation Trustees
July 2007
Advisor, The Japanese Institute of Certified Public Accountants (incumbent)
August 2007
Outside Director, Tokyo Stock Exchange Group (now Japan Exchange Group) 
October 2007
Governor, Tokyo Stock Exchange Regulation
April 2008
Specially appointed Professor, Chuo Graduate School of Strategic Management (business School)
June 2008
Outside Corporate Auditor, Sumitomo Corporation
June 2008
Outside Corporate Auditor, Takeda Pharmaceutical Company Limited
June 2008
Outside Director, Nomura Holdings, Inc.
June 2008
Outside Director, Nomura Securities Co., Ltd.
July 2008
Outside Director, Sumitomo Life Insurance Company
February 2009
Trustee and Vice Chairman, The IFRS Foundation Trustees
April 2010
Visiting Professor, Kansai University (incumbent)
May 2010
Outside Corporate Auditor, Seven & i Holdings Co., Ltd. 
April 2015
Fellow  (incumbent) and Advisory Board Member, Chuo University Business School
July 2017
Auditor, Chiba Gakuen Educational Association (incumbent)
June 2018
Chairman of Association, Certified Fraud Examiners Japan
June 2019
Outside Corporate Auditor of the Company (incumbent)
June 2023
Councilor of Association, Certified Fraud Examiners Japan
Major concurrent posts
Auditor, Chiba Gakuen Educational Association

Attended all 13 Board of Directors meetings of FY2023.

Attended all 11 Board of Corporate Auditors meetings of FY2023.

Shuichi Okuhara Outside Corporate Auditor(Independent Corporate Auditor)

Shuichi Okuhara

▼ Reasons for appointment

Shuichi Okuhara has extensive experience and a wide range of knowledge as a manager of a venture capital firm in a social environment that places importance on innovation through peer or cross-industrial partnerships. He also has professional expertise in finance and accounting as a certified public accountant and carries out audits suitable for the continually changing business environment. At the Board of Directors and Board of Auditors meetings, he provides sound advice, mainly on the healthcare industry in general, including investments and digital technologies. Accordingly, we expect him to reflect his experience in the audits of the Company concerning the appropriateness of the management decisions and execution of duties by the directors from an independent point of view as an outside corporate auditor.

▼ Career summary
April 1994
Joined Andersen Consulting Co., Ltd. (now Accenture Japan Ltd.)
January 1998
Joined Nippon Venture Capital
June 2008
Director and Investment manager, Nippon Venture Capital
April 2009
Representative Director and President, Nippon Venture Capital
June 2019
Representative Director and Chairman, Nippon Venture Capital (incumbent)
June 2020
Outside Corporate Auditor of the Company (incumbent)
Major concurrent posts
Representative Director and Chairman, Nippon Venture Capital

 

Attended all 13 Board of Directors meetings of FY2023.

Attended all 11 Board of Corporate Auditors meetings of FY2023.

Yoriko Goto Outside Corporate Auditor(Independent Corporate Auditor)

Takaoki Fujiwara

▼ Reasons for appointment

Yoriko Goto has professional expertise in finance and accounting as a certified public accountant and extensive management experience and broad insight through her service as Chairperson of the Board of Deloitte Tohmatsu Group and Deloitte Touche Tohmatsu LLC, among others. As she also serves as outside director of a financial institution, we believe that she will audit the Company from the finance, accounting, and management viewpoint. Accordingly, we expect her to reflect her experience in the audits of the Company concerning the appropriateness of the management decisions and execution of duties by the directors from an independent point of view as an outside corporate auditor. 

▼ Career summary
November 1983
Joined Deloitte Haskins and Sells International (now Deloitte Touche Tohmatsu LLC)
June 1996
Partner, Deloitte Touche Tohmatsu Limited (now Deloitte Touche Tohmatsu LLC)
June 2007
Japan Leader of Global Financial Services Industry, Deloitte Touche Tohmatsu Limited
October 2010
Managing Partner of Financial Services Industry, Deloitte Touche Tohmatsu LLC
October 2013
Member of Executive Committee of Deloitte Touche Tohmatsu LLC and Member of Board of Deloitte Touche Tohmatsu Limited
June 2018
Chairperson of the Board, Deloitte Touche Tohmatsu LLC and Deloitte Tohmatsu Group, and Member of Board, Deloitte Touche Tohmatsu Limited
November 2018
Member of Board, Deloitte Asia Pacific Limited
October 2022
President, Yoriko Goto CPA Office (incumbent)
October 2022
Outside Director (Member of the Audit and Supervisory Committee) , Sumitomo Mitsui Banking Corporation (incumbent)
June 2023
Outside Corporate Auditor of the Company (incumbent)
Major concurrent posts
Outside Director (Member of the Audit and Supervisory Committee) , Sumitomo Mitsui Banking Corporation

Attended all 11 Board of Directors meetings of FY2023.

Attended all 9 Board of Corporate Auditors meetings of FY2023.

Corporate Officers

Senior Executive Officer, Senior Vice President, Supply Supervisory Unit Koji Hanasaki, Ph.D.
Senior Executive Officer, Senior Vice President, R&D Supervisory Unit John Keller, Ph.D.
Senior Executive Officer, Senior Vice President, Healthcare Business Supervisory Unit Toshinobu Iwasaki, Ph.D.
Senior Executive Officer, Senior Vice President, Corporate Supervisory Unit and Corporate Strategy Division Kazuhiro Hatanaka 
Senior Executive Officer, Senior Vice President, Administration Division Ryuichi Kiyama, Ph.D.
Senior Executive Officer, Senior Vice President, Drug Discovery Research Division Yasuyoshi Isou, Ph.D.
Senior Executive Officer, President, Shionogi Pharma Co., Ltd Akira Kato, Ph.D.
Corporate Officer, Senior Vice President, Corporate Quality Assurance and Ethics & Compliance Management Division Takeshi Shiota, Ph.D.
Corporate Officer, Chairman and CEO of Ping An Shionogi Company Ltd. and Ping An Shionogi (Hong Kong) Company Ltd.
Tatsumori Yoshida
Corporate Officer, Senior Vice President, DX Promotion Division Masashi Deguchi, Ph.D.
Corporate Officer, Senior Vice President, Pharmaceutical Technology Research Division Yasunori Aoyama, Ph.D.
Corporate Officer, Senior Vice President, Integrated Disease Care Division Yousuke Miharu 
Corporate Officer, Senior Vice President, Drug Development and Regulatory Science Division Takeki Uehara, Ph.D.
Corporate Officer, Senior Vice President, Pharmaceutical Commercial Division Yoshinori Yurugi
Corporate Officer, President, Shionogi Healthcare Co., Ltd Satoru Yoshimoto
Corporate Officer, Senior Vice President, Vaccine Business Division Tetsuya Numa